Mark Sheptoff Financial Planning, LLC Veracyte, Inc. Transaction History
Mark Sheptoff Financial Planning, LLC
- $186 Million
- Q3 2024
A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 1,200 shares of VCYT stock, worth $54,072. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,200
Previous 1,200
-0.0%
Holding current value
$54,072
Previous $26,000
53.85%
% of portfolio
0.02%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding VCYT
# of Institutions
316Shares Held
81.8MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$351 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$349 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$226 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$222 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$191 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.23B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...